Lakeridge Wealth Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
SP
Lakeridge Wealth Management's AMGN Position: Q2 2026 in Review
Lakeridge Wealth Management increased its Amgen (AMGN) stake by 2.2% in Q2 2026, buying an estimated $4.79K and bringing the position to 642 shares worth $232K. The position accounts for 0.09% of the portfolio, ranked #167.
Lakeridge Wealth Management first reported a position in AMGN in Q4 2023 and has held it in 6 quarters since. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Lakeridge Wealth Management held 642 shares of Amgen worth $232K as of Q2 2026.
- Lakeridge Wealth Management bought 14 Amgen shares in Q2 2026, an estimated $4.79K.
- Amgen made up 0.09% of Lakeridge Wealth Management's portfolio in Q2 2026, its #167 holding.
- Lakeridge Wealth Management first reported a position in Amgen in Q4 2023 and has held it in 6 quarters since.
- 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Lakeridge Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.